Bristol-Myers Squibb Co. | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
16,385
15,879
16,560
19,427
20,776
22,561
Cost of Goods Sold (COGS) incl. D&A
4,675
3,740
3,754
4,932
5,651
6,486
Gross Income
11,710
12,139
12,806
14,495
15,125
16,075
SG&A Expense
8,670
8,865
8,868
9,316
9,509
9,681
EBIT
3,040
3,274
3,938
5,179
5,616
6,394
Unusual Expense
246
1,734
2,548
868
2,030
1,617
Non Operating Income/Expense
26
836
687
1,589
1,512
1,108
Interest Expense
199
203
184
167
196
183
Pretax Income
2,891
2,381
2,077
5,915
5,131
5,968
Income Tax
311
352
446
1,408
4,156
1,021
Consolidated Net Income
2,580
2,029
1,631
4,507
975
4,947
Net Income
2,563
2,004
1,565
4,457
1,007
4,920
Net Income After Extraordinaries
2,563
2,004
1,565
4,457
1,007
4,920
Net Income Available to Common
2,563
2,004
1,565
4,457
1,007
4,920
EPS (Basic)
1.54
1.20
0.93
2.65
0.61
3.01
Basic Shares Outstanding
1,644
1,657
1,667
1,671
1,645
1,633
EPS (Diluted)
1.54
1.20
0.93
2.65
0.61
3.01
Diluted Shares Outstanding
1,662
1,670
1,679
1,680
1,652
1,637
EBITDA
4,351
4,103
4,621
5,805
6,488
7,097
Non-Operating Interest Income
104
101
101
105
154
173
Minority Interest Expense
17
25
66
50
32
27
Equity in Affiliates (Pretax)
166
107
83
77
75
93
About Bristol-Myers Squibb
View Profile
